White Paper

Streamlined serialisation means serious savings

September 26, 2016

As global manufacturing regulations tighten to weed out counterfeit drugs from supply chains, suppliers have to come to terms with new demands being placed upon serialisation. World Pharmaceutical Frontiers talks to Jim Cummings, vice-president for the Americas at Adents, about how the company’s Pharma Suite is streamlining new input demands for the production line and helping manufacturers make significant long-term savings.

Download to find out more.